financetom
Business
financetom
/
Business
/
Mannapuram Finance MD told to get ED approval to deal in properties
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mannapuram Finance MD told to get ED approval to deal in properties
May 14, 2023 12:05 PM

Manappuram Finance on Sunday said that its Managing Director V P Nandakumar has received an interim stay order from the High Court of Kerala directing him to take prior approval of ED before dealing in his movable properties which were reportedly frozen by the investigating agency on allegations of money laundering.

Share Market Live

NSE

This is for a period of two weeks from May 12, 2023.

The company has been informed that Nandakumar will be approaching the court for modification of the conditions in the stay order.

Also read: Manappuram shares drop 13% on money laundering allegations, Rs 143 crore assets frozen

The Enforcement Directorate (ED) had reportedly frozen assets of Mannapuram Finance and Nandakumar on allegations of money laundering through illegal deposits from public.

These properties are worth around Rs 143 crore and located in Kerala’s Thirssur. ED had said that it had estimated Rs 143 crore to be collected from the public illegally, and despite an RBI order to return the same to the depositors, no proof of the repayment, which was claimed to be done, was recorded.

ED is investigating the role of the chief financial officer and other officials of the company in facilitating the alleged money laundering.

Also read: ED seizes Rs 360 crore worth of fixed deposits of Chettinad Group company

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved